Comparative effectiveness of a second TNF inhibitor versus a non-TNF biologic in the treatment of polyarticular course juvenile idiopathic arthritis.
Melissa L MannionShahla AminStephen J BalevicMin-Lee ChangColleen K CorrellLianne Kearsley-FleetKimme L HyrichTimothy Beukelmannull nullPublished in: Arthritis care & research (2024)
Most patients with polyarticular course JIA started TNFi rather than non-TNFi as their second biologic, and there were no differences in disease activity at 6 months.